Representative Publications In past years(# co-first author, * Corresponding author):
1. Zhang Y#, Wei M#, Wu Y#, Wang J#, Hong Y#, Huang Y#, Yuan L, Ma J, Wang K, Wang S, Shi Y, Wang Z, Guo H, Xiao J, Yang C, Ye J, Chen J, Liu Y, Fu B, Lan M, Gong P, Huang Z, Su Y, Chen Y, Zhang T, Zhang J, Zhu H, Yu H*, Yuan Q*, Cheng T*, Guan Y*, Xia N*. Cross-species tropism and antigenic landscapes of circulating SARS-CoV-2 variants. Cell Rep. 2022;38(12):110558.
2. Wu Y#, Wang S#, Zhang Y#, Yuan L#, Zheng Q#, Wei M#, Shi Y#, Wang Z, Ma J, Wang K, Nie M, Xiao J, Huang Z, Chen P, Guo H, Lan M, Xu J, Hou W, Hong Y, Chen D, Sun H, Xiong H, Zhou M, Liu C, Guo W, Guo H, Gao J, Gan C, Li Z, Zhang H, Wang X, Li S, Cheng T, Zhao Q, Chen Y, Wu T, Zhang T*, Zhang J*, Cao H*, Zhu H*, Yuan Q*, Guan Y*, Xia N*. Lineage-mosaic and mutation-patched spike proteins for broad-spectrum COVID-19 vaccine. Cell Host Microbe. 2022:S1931-3128(22)00524-8.
3. Ou S#, Huang Z#, Lan M#, Ye J, Chen J, Guo H, Xiao J, Zhuang S, Wu J, Yang C, Fang M, Su Y, Wu T, Ge S, Cheng T, Zhang Y*, Lin Y, Zhang Y*, Chen G*, Yuan Q*.The duration and breadth of antibody responses to 3-dose of inactivated COVID-19 vaccinations in healthy blood donors: An observational study. Front Immunol. 2022. 13:1027924.
4. Wang S#, Sun H#, Zhang Y#, Yuan L#, Wang Y#, Zhang T#, Wang S, Zhang J, Yu H, Xiong H, Tang Z, Liu L, Huang Y, Chen X, Li T, Ying D, Liu C, Chen Z, Yuan Q, Zhang J*, Cheng T*, Li S*, Guan Y*, Zheng Q*, Zheng Z*, Xia N*. Three SARS-CoV-2 antibodies provide broad and synergistic neutralization against variants of concern, including Omicron. Cell Rep. 2022;39(8):110862.
5. Su J#, Zheng J#, Huang W#, Zhang Y#, Lv C, Zhang B, Jiang L, Cheng T, Yuan Q, Xia N, Zhang J, Li L*, Li L*, Deng X*.PIKfyve inhibitors against SARS-CoV-2 and its variants including Omicron. Signal Transduct Target Ther. 2022;7(1):167.
6. Zhang Y#, Wang S#, Wu Y#, Hou W#, Yuan L#, Shen C#, Wang J, Ye J, Zheng Q, Ma J, Xu J, Wei M, Li Z, Nian S, Xiong H, Zhang L, Shi Y, Fu B, Cao J, Yang C, Li Z, Yang T, Liu L, Yu H, Hu J, Ge S, Chen Y, Zhang T, Zhang J, Cheng T*, Yuan Q*, Xia N*. Virus-Free and Live-Cell Visualizing SARS-CoV-2 Cell Entry for Studies of Neutralizing Antibodies and Compound Inhibitors. Small Methods.2021;5(2):2001031.
7. Chang L#, Hou W#, Zhao L#, Zhang Y#, Wang Y, Wu L, Xu T, Wang L, Wang J, Ma J, Wang L, Zhao J, Xu J, Dong J, Yan Y, Yang R, Li Y, Guo F, Cheng W, Su Y, Zeng J, Han W, Cheng T, Zhang J, Yuan Q, Xia N, Wang L. The prevalence of antibodies to SARS-CoV-2 among blood donors in China. Nat Commun. 2021;12(1):1383.
8. Wu Y#, Huang X#, Yuan L#, Wang S#, Zhang Y#, Xiong H#, Chen R, Ma J, Qi R, Nie M, Xu J, Zhang Z, Chen L, Wei M, Zhou M, Cai M, Shi Y, Zhang L, Yu H, Hong J, Wang Z, Hong Y, Yue M, Li Z, Chen D, Zheng Q, Li S, Chen Y, Cheng T, Zhang J*, Zhang T*, Zhu H*, Zhao Q*, Yuan Q*, Guan Y*, Xia N*. A recombinant spike protein subunit vaccine confers protective immunity against SARS-CoV-2 infection and transmission in hamsters. Sci Transl Med. 2021;13(606):eabg1143.
9. Yuan L#, Zhang Y#, Liu X#, Chen Y, Zhang L, Cao J, Li X, Wang M, Wu K, Zhang J, Liu G, Tang Q, Yuan Q, Cheng T, Xia N. Agonist c-Met Monoclonal Antibody Augments the Proliferation of hiPSC-derived Hepatocyte-Like Cells and Improves Cell Transplantation Therapy for Liver Failure in Mice. Theranostics. 2019;9(7):2115-2128.
10. Zhang Y#, Gao Y#, Cao J, Zhao J, Zhang T, Yang C, Xiong H, Wang Y, Ou S, Cheng T, Chen C, Yuan Q, Xia N. Robust in vitro assay for analyzing the neutralization activity of serum specimens against hepatitis B virus. Emerg Microbes Infect. 2019;8(1):724-733.
